• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/16

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

16 Cards in this Set

  • Front
  • Back
Vascular Complications (Microvascular) and (Macrovascular)
Retinopathy, Neuropathy, and Nephropathy
CHD, PVD, CVD
Non Vascular Complications
Gastroparesis
Sexual Dysfunction
Infections
Skin changes
Periodontal disease
Hearing loss
Diabetes Control and Complications Trial (DCCT)
Study development and complications
Results: Difference in A1C
Decreased retinopathy, neuropathy, microalbuminurea
Hypoglycemic and weight gain more common with intensive therapy
*Good glycemic control of conventional therapy
United Kingdom Prospective Diabetes Study (UKPDS)
Incidence of vascular complications related to BP and glycemic control
Decreased A1C, microalbuminuria, microvascular complications, BP control reduced both vascular complications
Metformin reduced macrovascular risk
ACCORD, ADVANCE, VADT
Showed that short term glycemic control does not positively effect macrovascular risk in Type 2
Retinopathy Pathophysiology
Small vessels in retina became damaged and cause aneurysm.
Results in edema, fatty deposition, retinal dettachment
Retinopathy Risk Factors
Hyperglycemia
HTN
Smoking
Retinopathy Prognosis and Treatment
Reversible!
Achieve glycemic control or laser surgery
Retinopathy Screening in Type 1
Routine dilated retinal exams
Within 3-5 years after dx and annually
Retinopathy Screening for Type 2
Routine dilated retinal exams
Shortly after diagnosis and annually
Nephropathy Risk Factors
Hyperglycemia
HTN
Hyperlipidemia
Ethnicity: Native, Hispanic, or African Americans
Smoking
Nephropathy Screening
SCr annually to estimate C=GFR
Urine Collection
- annually
+ at least 2 - 3 tests in 3 - 6 months
When to Screen for Nephropathy Type 1
After 5 years disease duration
When to Screen for Nephropathy for Type 2
At onset of Diagnosis and During Pregnancy
Microalbumin Screening
Small random sample
Measures mcg albumin: mg Cr
Factors that May Affect Results for Microalbumin screening
Exercise
UTI
HTN
Hyperglycemia
HF